Cargando…
Low density of CD3+, CD4+ and CD8+ cells is associated with increased risk of relapse in squamous cell cervical cancer
The purpose of this study was to investigate the prognostic value of the primary in situ cellular immune response in cervical squamous cell carcinoma. A study of 102 women treated for stage IB and IIA disease, between 1990 and 2000, was performed. Paraffin-embedded cervical tissue processed at the t...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360435/ https://www.ncbi.nlm.nih.gov/pubmed/17940503 http://dx.doi.org/10.1038/sj.bjc.6604001 |
_version_ | 1782153048786731008 |
---|---|
author | Nedergaard, B S Ladekarl, M Thomsen, H F Nyengaard, J R Nielsen, K |
author_facet | Nedergaard, B S Ladekarl, M Thomsen, H F Nyengaard, J R Nielsen, K |
author_sort | Nedergaard, B S |
collection | PubMed |
description | The purpose of this study was to investigate the prognostic value of the primary in situ cellular immune response in cervical squamous cell carcinoma. A study of 102 women treated for stage IB and IIA disease, between 1990 and 2000, was performed. Paraffin-embedded cervical tissue processed at the time of diagnosis was immunostained for CD3+ (T cells), CD4+ (T helper/regulatory T cells) and CD8+ (cytotoxic T cells) cells. Immune cell profile densities were estimated using stereology. Both intra- and peritumoural cell densities were estimated. Using Cox's proportional hazards regression modelling we found an increase in cell density to decrease the risk of relapse for all three cell types. The density of peritumoural CD3+ cells seems to have the strongest potential for predicting relapse. An increase in CD3+ cell density from 795 to 2043 cells per mm(2) (25–75 percentile) reduced the hazard ratio to 0.27. |
format | Text |
id | pubmed-2360435 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-23604352009-09-10 Low density of CD3+, CD4+ and CD8+ cells is associated with increased risk of relapse in squamous cell cervical cancer Nedergaard, B S Ladekarl, M Thomsen, H F Nyengaard, J R Nielsen, K Br J Cancer Molecular Diagnostics The purpose of this study was to investigate the prognostic value of the primary in situ cellular immune response in cervical squamous cell carcinoma. A study of 102 women treated for stage IB and IIA disease, between 1990 and 2000, was performed. Paraffin-embedded cervical tissue processed at the time of diagnosis was immunostained for CD3+ (T cells), CD4+ (T helper/regulatory T cells) and CD8+ (cytotoxic T cells) cells. Immune cell profile densities were estimated using stereology. Both intra- and peritumoural cell densities were estimated. Using Cox's proportional hazards regression modelling we found an increase in cell density to decrease the risk of relapse for all three cell types. The density of peritumoural CD3+ cells seems to have the strongest potential for predicting relapse. An increase in CD3+ cell density from 795 to 2043 cells per mm(2) (25–75 percentile) reduced the hazard ratio to 0.27. Nature Publishing Group 2007-10-22 2007-10-16 /pmc/articles/PMC2360435/ /pubmed/17940503 http://dx.doi.org/10.1038/sj.bjc.6604001 Text en Copyright © 2007 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Molecular Diagnostics Nedergaard, B S Ladekarl, M Thomsen, H F Nyengaard, J R Nielsen, K Low density of CD3+, CD4+ and CD8+ cells is associated with increased risk of relapse in squamous cell cervical cancer |
title | Low density of CD3+, CD4+ and CD8+ cells is associated with increased risk of relapse in squamous cell cervical cancer |
title_full | Low density of CD3+, CD4+ and CD8+ cells is associated with increased risk of relapse in squamous cell cervical cancer |
title_fullStr | Low density of CD3+, CD4+ and CD8+ cells is associated with increased risk of relapse in squamous cell cervical cancer |
title_full_unstemmed | Low density of CD3+, CD4+ and CD8+ cells is associated with increased risk of relapse in squamous cell cervical cancer |
title_short | Low density of CD3+, CD4+ and CD8+ cells is associated with increased risk of relapse in squamous cell cervical cancer |
title_sort | low density of cd3+, cd4+ and cd8+ cells is associated with increased risk of relapse in squamous cell cervical cancer |
topic | Molecular Diagnostics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360435/ https://www.ncbi.nlm.nih.gov/pubmed/17940503 http://dx.doi.org/10.1038/sj.bjc.6604001 |
work_keys_str_mv | AT nedergaardbs lowdensityofcd3cd4andcd8cellsisassociatedwithincreasedriskofrelapseinsquamouscellcervicalcancer AT ladekarlm lowdensityofcd3cd4andcd8cellsisassociatedwithincreasedriskofrelapseinsquamouscellcervicalcancer AT thomsenhf lowdensityofcd3cd4andcd8cellsisassociatedwithincreasedriskofrelapseinsquamouscellcervicalcancer AT nyengaardjr lowdensityofcd3cd4andcd8cellsisassociatedwithincreasedriskofrelapseinsquamouscellcervicalcancer AT nielsenk lowdensityofcd3cd4andcd8cellsisassociatedwithincreasedriskofrelapseinsquamouscellcervicalcancer |